Propensity-score matching The GLP-1 RAs and SGLT2 inhibitor cohorts were meticulously 1:1 propensity-matched, incorporating three years of records before the index date
Medical care costs included costs associated with office visits, hospital outpatient care, emergency department visits, inpatient stays, and home health care services
Prioritize Balanced Meals Many people taking GLP-1 medications unintentionally eat too little because their appetite is greatly reduced
Outcomes including any change in body weight, appetite, or metabolic markers vary from patient to patient
They are best suited for individuals who: Struggle with stubborn fat despite diet and exercise Experience frequent hunger or cravings Have metabolic resistance or hormonal imbalances Need medically guided weight management At VeCura ReSculpt, every GLP-1 plan begins with a detailed medical assessment